Sailong Pharmaceutical Group Co., Ltd. (002898.SZ) SHZ

Currency In CNY

AD

Valuation

Market Cap2.4B
Enterprise Value2.43B
P/E Ratio-11.22
PEG Ratio0.12
Price/Sales Ratio2.36
Price/Book Ratio3.93
Enterprise/Revenue2.45
Enterprise/EBITDA-19.91

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin-0.21
Operating Margin-0.19
AD

Management Effectiveness

Return On Assets-0.15
Return On Equity-0.3

Income Statement

Revenue518.76M
Revenue/Share3.51
Gross Profit73.55M
EBITDA-53.81M
Net Income-121.17M
Diluted EPS-0.69

Balance Sheet

Total Cash29.21M
Total Cash/Share0.17
Total Debt85.66M
Total Debt/Equity0.23
Current Ratio0.85
Book Value Per Share2.15

Price History

52-Week Change-29.54
52-Week High17.49
52-Week Low8.3
Moving Average 50 Days10.31
Moving Average 200 Days12.53

Statistics

Average Volume862,084
Shares Outstanding176M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio-0.03
Last Split Factor11:10
Last Split DateJuly 16, 2020
AD